# Andrew Banks

> Andrew Banks is a seed investor at ABRY Partners (London) backing Biopharma and Biotechnology. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [ABRY Partners](https://shizune.co/investors/profile/abry-partners)
- Location: London, United Kingdom
- Total investments: 1
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/in/andybanx
- X (Twitter): http://twitter.com/andybanx
- Website: http://thetruecapital.com

Andrew Banks is a seed investor at ABRY Partners in London focused on Biopharma and Biotechnology. Andrew Banks - Chairman and Co-Founder @ ABRY Partners

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biopharma | 1 | 100% |
| Biotechnology | 1 | 100% |
| Pharmaceutical | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Juvenescence | Juvenescence Limited is a British Virgin Islands-based holding company that invests in human aging and longevity. Juvenescence has raised $111M to build an ecosystem and pipeline of assets targeting aging, age-related disease, and regeneration. Juvenescence believes that recent scientific and medical advances will enable the development oftherapeutics that meaningfully extend human healthspan and eventually lifespan. A meaningful increase in lifespan in the already aging world will have profound implications on all sectors of society, and in particular healthcare, education, insurance, and leisure.The company creates and partners with new companies with longevity-related therapeutics, by in-licensing compounds from academia and industry, or forming joint ventures with the foremost longevity scientists and leading research institutions. Their work is based on a novel scientific understanding of the underlying biological causes of aging, to create evidence-based therapeutics that can treat diseases of aging.Juvenescence's goal is to extend both lifespan and healthspan, by developing therapeutics that slow aging and promote juvenescence. | $12.3M | Seed | Jan 08, 2018 |  |

1 of 1 investments shown.

## Co-investors
- [Apeiron Investment Group](https://shizune.co/investors/profile/apeiron-investment-group) — VC Fund, 1 deal together
- [Foresite Capital](https://shizune.co/investors/profile/foresite-capital) — VC Fund, 1 deal together

## About ABRY Partners

VC Fund · Boston, United States

ABRY Partners is a private equity firm specializing in late-stage; total buy-outs of financial investors, families, publicly-traded or strategic owners; acquisition roll-ups, platform acquisitions; leveraged buyouts; industry consolidations; add-on acquisitions; mezzanine, recapitalizations, turnaround; and growth capital investments. It prefers toinvest in media, communication, business services, education, entertainment, healthcare services, information services, and online media industries with a focus on television and radio broadcasting, cable television, business-to-business, magazine publishing, newsletter publishing, conventions/trade shows, for-profit training, couponing, monitoring services, telephone companies, communications towers, consumer magazine publishing, recorded music libraries, proprietary database providers, wireless communications, and in-store advertising. The firm typically invests between $25 million and $150 million of equity in the case of the private equity fund or between $15 million and $50 million of mezzanine/senior equity capital in its portfolio companies. It seeks to invest for a period between three years and seven years. ABRY Partners, LLC was co-founded in 1989 and is based in Boston, Massachusetts.

5 contacts available at ABRY Partners.

| Name | Title | Profile |
| --- | --- | --- |
| Chris Anzivino | Vice President | https://shizune.co/investors/profile/chris-anzivino |
| Nicholas Scola | Partner | https://shizune.co/investors/profile/nicholas-scola |
| TJ Rose | Partner | https://shizune.co/investors/profile/t-j-rose |
| Anders Bjork | Partner | https://shizune.co/investors/profile/anders-bjork-8841 |
| Andrew Banks | Chairman and Co-Founder | https://shizune.co/investors/profile/andrew-banks |

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Blockchain Founders Fund](https://shizune.co/investors/profile/blockchain-founders-fund) — VC Fund
- [Force Over Mass Capital](https://shizune.co/investors/profile/force-over-mass-capital) — VC Fund
- [NewBound Venture Capital](https://shizune.co/investors/profile/excelsior-financial-partners) — VC Fund

## Featured in investor lists
- [All Investors in Isle of Man](https://shizune.co/investors/investors-isle-of-man)
- [Biotech Investors in Isle of Man](https://shizune.co/investors/biotech-investors-isle-of-man)
- [All Angel Investors in Isle of Man](https://shizune.co/investors/angel-investors-isle-of-man)
- [Health Care Angel Investors in Ireland](https://shizune.co/investors/health-care-angel-investors-ireland)

## FAQ

### What does Andrew Banks invest in?

Andrew Banks invests primarily in Biopharma, Biotechnology and Pharmaceutical startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in Isle of Man. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co